Breaking

Telefonica scales back Huawei use in Europe, maintains course in Latin America
What made Marvell stock pop 10% on Wednesday?
UBS issues a bold call on Peloton stock, see PTON shares nearly doubling from here
Harley Davidon shares jump 16% after plans to monetise finance unit to private equity
Cathie Wood loads up on Bitmine stock: should you too?
Inside the U.S. Crypto Report 2025, 68M Users, $4.8B VC Inflow & Market Clarity
Robinhood Reports 45% Revenue Jump and Doubles Crypto Earnings
Why Experts Say Ruvi AI (RUVI), Not Tron (TRX), Is the Top Summer Pick, Audited Token Demand Has Highly Surged After CoinMarketCap Listing

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Top

Type above and press Enter to search. Press Esc to cancel.